We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Intradiscal Steroid Temporarily Alleviates Lower Back Pain

By HospiMedica International staff writers
Posted on 06 Apr 2017
Print article
Image: Steroid injections to treat lower back pain show no long-term benefit, according to a new study (Photo courtesy of Getty Images).
Image: Steroid injections to treat lower back pain show no long-term benefit, according to a new study (Photo courtesy of Getty Images).
A single intradiscal injection of glucocorticoid (GC) is associated with reduced short-term low back pain (LBP) in patients with active discopathy, according to a new study.

Researchers at Université Paris Descartes, Hôpital Roger Salengro, and other institutions conducted a prospective, randomized, controlled study involving 135 patients with chronic LBP with active discopathy as demonstrated on magnetic resonance imaging (MRI), treated at three tertiary care centers in France. Study patients received a single GC intradiscal injection of 25 mg prednisolone acetate during discography (67 patients), while control patients underwent discography alone (68 patients).

The researchers found that percentage of patients with LBP intensity lower than 40 on an 11-point numerical rating scale was higher in the study group than the control group at one month after the intervention (55.4% versus 33.3%, respectively); there was no between-group difference in LBP intensity at 12 months. Secondary outcomes, such as spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and analgesic use did not differ between the groups at one or 12 months. The study was published on March 21, 2017, in Annals of Internal Medicine.

“Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition; the findings are consistent with earlier studies,” concluded lead Christelle Nguyen, MD, PhD, of Paris Descartes University, and colleagues. “Patients who did or didn't receive a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression, and continued use of non-narcotic pain pills.”

Many spinal conditions, including a lumbar herniated disc, can cause inflammation or pressure on the nerve roots leading out of the spine, resulting in pain, tingling, or numbness. A lumbar epidural GC injection may be used to reduce the inflammation around the spinal nerves. But studies have shown that epidural steroid injections play a limited role in providing short-term pain relief, with an average time of two to six weeks after injection.

Print article


Copyright © 2000-2020 Globetech Media. All rights reserved.